Alison Ritchie
Impact in
- Oncology top 5%
- Metal complexes synthesis and properties
- Organic Chemistry top 5%
- Ferrocene Chemistry and Applications
- Organometallic Complex Synthesis and Catalysis
- Click Chemistry and Applications
Papers in
-
- Receptor Mechanisms and Signaling 3
- Oncology 11
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Morwenna Muir (4 shared papers)Jeffrey L. Cummings (7 shared papers)Peter J. Sadler (1 shared paper)Duncan I. Jodrell (1 shared paper)Rhona Aird (1 shared paper)Robert A. Morris (1 shared paper)Simon P. Langdon (14 shared papers)William R. Miller (9 shared papers)
- Journals
- European Journal of Cancer (4 papers)Biomaterials Science (3 papers)Biochemical Pharmacology (2 papers)Annals of Oncology (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Alison Ritchie
42 papers receiving 1.6k citations
Alison Ritchie's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 671
- Organic Chemistry 478
- Reproductive Medicine 90
- Toxicology 36
- Molecular Biology 595
Countries citing papers authored by Alison Ritchie
This map shows the geographic impact of Alison Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Ritchie more than expected).
Fields of papers citing papers by Alison Ritchie
This network shows the impact of papers produced by Alison Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Ritchie. The network helps show where Alison Ritchie may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison Ritchie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer Hit paper breakdown → | 2002 | 537 |
| 2 | Does age matter? The impact of rodent age on study outcomes Hit paper breakdown → | 2016 | 263 |
| 3 | Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. | 1992 | 74 |
| 4 | 2001 | 60 | |
| 5 | 1994 | 54 | |
| 6 | 1996 | 52 | |
| 7 | 2020 | 50 | |
| 8 | 2021 | 47 | |
| 9 | 1997 | 44 | |
| 10 | 1993 | 38 | |
| 11 | 2014 | 34 | |
| 12 | Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen. | 1998 | 33 |
| 13 | 1998 | 27 | |
| 14 | 2016 | 25 | |
| 15 | 2001 | 25 | |
| 16 | 1998 | 25 | |
| 17 | 2013 | 23 | |
| 18 | 1995 | 23 | |
| 19 | 2020 | 22 | |
| 20 | 2020 | 21 |
About Alison Ritchie
Alison Ritchie is a scholar working on Molecular Biology, Oncology, Genetics, Biomaterials and Biomedical Engineering, having authored 44 papers that have together received 1.6k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (5 papers), Ovarian cancer diagnosis and treatment (3 papers), Receptor Mechanisms and Signaling (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Dendrimers and Hyperbranched Polymers (3 papers). The work is most often cited by research in Oncology (671 citations), Organic Chemistry (478 citations), Reproductive Medicine (90 citations), Toxicology (36 citations) and Molecular Biology (595 citations). Alison Ritchie has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Morwenna Muir, Jeffrey L. Cummings, Peter J. Sadler, Duncan I. Jodrell, Rhona Aird, Robert A. Morris, Simon P. Langdon, William R. Miller, John F. Smyth and Peter Mullen. Their work appears in journals such as European Journal of Cancer, Biomaterials Science, Biochemical Pharmacology, Annals of Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.